<DOC>
	<DOCNO>NCT01524159</DOCNO>
	<brief_summary>The purpose study evaluate effect dietary supplementation bromelain ( proteolytic enzyme pineapple plant ) reduction plasma fibrinogen level among type 2 diabetic subject high risk cardiovascular disease . The null hypothesis [ Ho ] : significant improvement plasma fibrinogen , serum lipid profile , blood pressure , BMI , waist circumference C-reactive protein subject type 2 diabetes risk CVD follow intervention bromelain supplementation compare placebo group . The alternative hypothesis [ H1 ] : significant improvement plasma fibrinogen , serum lipid profile , blood pressure , BMI , waist circumference C-reactive protein subject type 2 diabetes risk CVD follow intervention bromelain supplementation compare placebo group .</brief_summary>
	<brief_title>Bromelain Cardiovascular Risk Factors Diabetes</brief_title>
	<detailed_description>According American Heart Association ( 2010 ) , heart disease stroke No . 1 cause death disability among people type 2 diabetes . At least 65 % people diabetes die form heart disease stroke . Type 2 diabetes associate two fourfold increase incidence ischemic cardiovascular event markedly enhance risk stroke ( Coutinho et al , 1999 ) due variety associate risk factor include high blood pressure , lipid disorder , high low-density lipoprotein ( LDL ) cholesterol , high triglyceride , low high-density lipoprotein ( HDL ) cholesterol , smoking , obesity , lack physical activity poorly control blood sugar ( American Heart Association 2010 ) . Bromelain , crude extract pineapple plant , first introduce therapeutic compound 1957 ( Heinicke &amp; Gortner , 1957 ) . Heinicke et al . ( 1971 ) report bromelain effective use cardiovascular disease inhibitor blood platelet aggregation , minimize risk arterial thrombosis embolism . A literature review identify three human study ( Honolulu Germany ) . In view review valuable therapeutic property bromelain cardiovascular disease , need study confirm bromelain 's use cardiovasular disease . This study randomize placebo control , parallel design , double blind , pilot efficacy study carry Hebei Yiling Hospital , China . The study assess effect 12 week bromelain ( 1050mg/day ) supplementation plasma fibrinogen level compare usual care . Study participant type 2 diabetes risk develop cardiovascular disease .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Age 18 year old Diagnosed type 2 diabetes ( HbA1C &gt; 6,5 % ) , risk CVD indicate follow risk parameter : total cholesterol 5.0 6.2 mmol/l ( 195.0 241.8 mg/dL ) , Body Mass Index ( BMI ) &gt; 25 kg/m2 Waist circumference &gt; 101.6 cm ( 40 inch ) men &gt; 88.9 cm ( 35 inch ) woman Triglycerides &gt; 1.7 mmol/L ( 150mg/dL ) HDLcholesterol &lt; 1 mmol/L ( 40 mg/dL ) men , &lt; 1.3 mmol/L ( 50 mg/dL ) woman LDLcholesterol &gt; 2.6 mmol/L ( 100 mg/dL ) Blood pressure &gt; 140/90mm Hg Pregnant try become pregnant lactating woman Subjects unwilling unable comply study procedure Subjects severe health problem include renal disease , liver disease , cardiovascular disease , chronic ill health condition . Subjects drug cardiovascular medication like warfarin , aspirin . Subjects take statin . Subjects take bromelain supplement herbal supplement know effective e.g . cinnamon . Subjects history allergic reaction bee sting , olive tree pollen pineapple . Subjects history occupational inhalant/skin contact bromelain . Subjects diabetes ketoacidosis recently ( past 2 week ) . Unable provide inform consent i.e . unable follow diet control advice willing follow study procedure . Subjects Chinese herb medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>cardiovascular disease</keyword>
</DOC>